LACTOLOGY FOUNDATION

Sterculia (ATC A06AC03) is a bulk-forming laxative of plant origin that appears compatible with breastfeeding when used in recommended doses, with negligible expected transfer into breast milk and low risk for the nursing infant.medpedia.framar+3

Monograph title and scope

Sterculia (karaya gum) – bulk-forming laxative (ATC A06AC03): pharmacology, safety in pregnancy and lactation, and toxicological considerations.medicinenet+2

Pharmacology and general use

Sterculia is a natural dietary fibre obtained from the exudate or plant material of Sterculia species, trees native to tropical regions and particularly Sterculia urens in India.wikipedia+2
It is classified in ATC group A06AC03 as a bulk-forming laxative that increases stool bulk and water content, thereby stimulating colonic motility and facilitating defecation.atcddd.fhi+3

The granules are usually administered orally with a large volume of water, commonly 250 mL per dose, once or twice daily.rxlist+2
It is used for the relief of occasional constipation, for maintenance of regular bowel habits, and as a mechanical bulking agent in the gastrointestinal lumen.seslhd.nsw+2

Mechanism of action and pharmacokinetics

Sterculia contains complex acid polysaccharides and non-absorbable fibre that hydrate and swell in the intestinal tract, increasing stool volume and softness.pmc.ncbi.nlm.nih+2
The increased bulk stimulates peristalsis through distension of the intestinal wall, promoting physiological evacuation without significant systemic pharmacodynamic effects.medicinenet+1

Available data indicate that sterculia is not systemically absorbed to a clinically relevant extent, which minimizes systemic exposure and limits passage into breast milk or across the placenta.sps+3
Because absorption is negligible, classical pharmacokinetic parameters (Cmax, AUC, protein binding) are not well defined, and the effect is primarily local within the gut.ncbi.nlm.nih+2

Indications, dosing and clinical positioning

Sterculia-containing products are indicated for functional constipation and conditions requiring soft, bulky stools, such as situations where straining should be avoided.rxlist+2
They are also used as dietary fibre supplements and, in some formulations, as thickening agents or components in stoma care and denture adhesives, though these uses are not directly related to lactation-toxicology.pmc.ncbi.nlm.nih+1

Typical adult dosing consists of 1–2 sachets once or twice daily, taken with ample fluid; paediatric dosing below 12 years is usually not established and should follow specific product information.medicinenet+1
Bulk-forming laxatives such as sterculia are generally positioned as first-line pharmacological options in constipation management during pregnancy and breastfeeding, after lifestyle measures.breastfeedingnetwork+2

Pregnancy: toxicological and safety aspects

There is limited direct human data on sterculia use in pregnancy, but its minimal systemic absorption suggests a low potential for teratogenicity or fetal toxicity when used within recommended doses.ncbi.nlm.nih+3
Guidelines on constipation in pregnancy recommend bulk-forming laxatives (including sterculia) as preferred agents, given their local mechanism and favourable safety profile compared with stimulant or mineral oil laxatives.seslhd.nsw+1

No specific pattern of congenital anomalies or pregnancy complications has been attributed to sterculia, and overall experience with bulk-forming laxatives suggests no increase in the risk of birth defects.ncbi.nlm.nih+1
Nevertheless, use in pregnancy should be guided by clinical judgment, with emphasis on non-pharmacological measures (diet, fluids, exercise) and short-term, lowest effective doses when medication is required.breastfeedingnetwork+1

Lactation: transfer into milk and infant risk

Sterculia is considered unlikely to pass into breast milk to any clinically significant extent because it is essentially not absorbed from the maternal gastrointestinal tract.sps+3
Professional guidance states that bulk-forming laxatives can be used during breastfeeding, as they produce negligible levels in breast milk and are therefore not expected to pose a risk to full-term, healthy infants.sps+3

In the absence of direct milk-level measurements for sterculia, these recommendations rely on its pharmacological class and physicochemical properties, which favour minimal systemic bioavailability.seslhd.nsw+2
Reported experience does not indicate adverse effects in breastfed infants whose mothers use bulk-forming laxatives, and sterculia-containing preparations are generally regarded as compatible with lactation when used as directed.breastfeedingnetwork+2

Clinical lactation recommendations

·        Prefer non-pharmacologic measures first (dietary fibre, fluid intake, physical activity) and reserve pharmacotherapy for persistent symptoms.breastfeedingnetwork+1

·        When a laxative is required during breastfeeding, a bulk-forming agent such as sterculia is an appropriate first choice, especially in otherwise healthy, term infants.sps+2

·        Use the lowest effective dose and avoid chronic, high-dose use without medical supervision, although routine doses are unlikely to affect milk or infant.sps+1

Breastfeeding mothers should be counselled to take sterculia with plenty of water to optimize efficacy and reduce the risk of gastrointestinal side effects such as bloating or obstruction.medicinenet+1
If the breastfed infant develops unusual gastrointestinal symptoms, growth disturbance, or other health issues, maternal medication – including laxatives – should be re-evaluated, though a causal role of sterculia is unlikely.ncbi.nlm.nih+2

Toxicology and adverse effects

Sterculia is generally well tolerated, with common adverse effects related to its bulking action, including abdominal discomfort, bloating, flatulence, and, rarely, intestinal obstruction if taken with insufficient fluid or in patients with underlying stenosis.rxlist+2
Hypersensitivity reactions to plant-derived fibre are possible but uncommon; caution is advised in patients with known allergy to sterculia or similar plant gums.rxlist+1

A severe liver injury case has been reported in association with Sterculia versicolor-derived gum used as a thickener and laxative, indicating that idiosyncratic hepatotoxicity is possible though extremely rare.pmc.ncbi.nlm.nih
Given the rarity and uncertainty of mechanism, this signal does not currently change the general risk assessment for routine laxative use but supports the need for vigilance in unexplained hepatic injury.pmc.ncbi.nlm.nih

Bulk-forming laxatives can theoretically exacerbate gastrointestinal obstruction or impaction in patients with structural bowel disease or impaired motility, and such conditions are listed as contraindications or precautions.seslhd.nsw+2
There is no specific evidence of direct toxicity to the breastfed infant from maternal sterculia use, and the main safety focus remains on maternal gastrointestinal tolerance and rare hypersensitivity or hepatic events.pmc.ncbi.nlm.nih+2

Drug interactions and special warnings

Because sterculia acts locally and is not absorbed, clinically relevant systemic drug interactions are unlikely.medicinenet+1
However, its bulking effect may theoretically alter the absorption of concomitantly administered oral drugs if taken simultaneously, so spacing administration by at least one to two hours is prudent.seslhd.nsw+1

Sterculia should always be taken with adequate fluid to prevent esophageal or intestinal impaction, particularly in elderly patients or those with swallowing difficulties.medicinenet+1
It should be avoided or used under specialist supervision in patients with known intestinal obstruction, severe fecal impaction, or structural narrowing of the gut.rxlist+2

Webpage-style structure (sections for implementation)

·        Overview and ATC classification (A06AC03 sterculia; plant-derived bulk-forming laxative).medpedia.framar+2

·        Pharmacology and mechanism of action (local fibre effect, increased stool bulk, minimal absorption).pmc.ncbi.nlm.nih+2

·        Indications and dosing (functional constipation; adult sachet dosing with water).rxlist+2

·        Use in pregnancy (preferred bulk-forming option; low systemic exposure; guideline-based recommendations).ncbi.nlm.nih+1

·        Use during lactation (expected negligible passage into milk; compatibility with breastfeeding; clinical advice).breastfeedingnetwork+4

·        Toxicology and adverse effects (gastrointestinal events, rare hepatotoxicity, hypersensitivity).pmc.ncbi.nlm.nih+2

·        Precautions, contraindications, and counselling points (fluid intake, obstruction risk, spacing from other oral drugs).seslhd.nsw+2